Advanced search×

Sentinel lymph node biopsy in esophageal cancer: has its time come?

Jie J Zhang, Haiquan H Chen, and James D JD Luketich

Ann Surg 252(2):413-4; author reply 415 (2010) PMID 20647912

DOI: 10.1097/SLA.0b013e3181e9f098
Version: za2963e q8zab q8zb8 q8zcd q8zdd q8ze3 q8zf7 q8zgc
Buy PDF

Similar articles you may find interesting…

  1. Diagnostic performance of (18)F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with (18)F-fl...
    Masatoyo Nakajo, Masayuki Nakajo, and Chihaya Koriyama

    Eur J Nucl Med Mol Imaging (2013) PMID 23653240

    All 30 primary cancers (43.0 ± 20.0 mm, range 14 - 85 mm) were visualized by both tracers, but none of the FLT SUVmax values exceeded the FDG SUVmax values in any of the primary cancers (6.6 ± 2.4 vs. 13.6 ± 5.8, p < 0.001). The sensitivity, specificity and accuracy for detect...
    Buy PDF
  2. CCL19/CCR7 upregulates heparanase via specificity protein-1 (Sp1) to promote invasion of cell in lung cancer.
    Qingfu Zhang, Limei Sun, and Xueshan Qiu

    Tumour Biol (2013) PMID 23649655

    We demonstrated that human lung adenocarcinoma A549 cells treated with recombinant human CCL19 could obviously upregulate the expression of Sp1 and heparanase at both the mRNA and protein levels. After blockage of CCR7, Sp1 and heparanase expressions were inhibited. Following inhibition of Sp1, hepa...
    Buy PDF
  3. Extended Lymphadenectomy in Gastric Cancer Is Debatable.
    Vivian E Strong and Sam S Yoon

    World J Surg (2013) PMID 23649527

    We then discuss more contemporary studies that support more extensive lymphadenectomy with a minimum of 16 lymph nodes for adequate staging. The 15-year follow-up of the Netherlands trial now demonstrates an improved disease-specific survival and locoregional recurrence in the D2 group. A prospectiv...
    Buy PDF